ArticleFrontiers in immunology2026

Dynamic serum tumor-marker and immune-inflammatory biomarker changes for risk stratification of immune checkpoint inhibitor-associated myasthenia gravis in non-small cell lung cancer.

Pin Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.